Dataset Information

Fertility preservation in women with cancer: a national study about French oncologists awareness, experience, and feelings.

ABSTRACT:

Purpose

This study was designed to evaluate patient management and quality of information given by French oncologists to cancer women concerning fertility issues and possibilities of fertility preservation.

Methods

An online survey was sent to 1161 physicians in all major cancer centers throughout France between May 2012 and January 2013.

Results

A total of 102 responses were received and analyzed. Only 46% of all physicians surveyed reported discussing infertility risks with patients of reproductive age and 22% referred them to a fertility center before beginning treatments. Only 14% of practitioners considered themselves knowledgeable in FP techniques and ovarian transposition was the most frequently mentioned technique in consultation.

Conclusion

This study is at the best of our knowledge the first nationwide survey to assess the state of the art in oncofertility management. It highlights inadequate management of fertility preservation for female patients in France. Physicians reported lacking knowledge and tools that would allow them to provide patients with appropriate information. A better collaboration between cancer and fertility centers needs to be organized in France as already organized in other countries.

SUBMITTER: Sallem A

PROVIDER: S-EPMC6150902 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Fertility preservation in women with cancer: a national study about French oncologists awareness, experience, and feelings.

Sallem Amira A Shore Joanna J Ray-Coquard Isabelle I Ferreux Lucile L Bourdon Mathilde M Maignien Chloé C Patrat Catherine C Wolf Jean-Philippe JP Pocate-Cheriet Khaled K

Journal of assisted reproduction and genetics 20180704 10

<h4>Purpose</h4>This study was designed to evaluate patient management and quality of information given by French oncologists to cancer women concerning fertility issues and possibilities of fertility preservation.<h4>Methods</h4>An online survey was sent to 1161 physicians in all major cancer centers throughout France between May 2012 and January 2013.<h4>Results</h4>A total of 102 responses were received and analyzed. Only 46% of all physicians surveyed reported discussing infertility risks wi ...[more]

PMID: 29974370

Similar Datasets

Project description:Although breast cancer (BC) occurs more often in older women, it is the most commonly diagnosed malignancy in women of childbearing age. Owing to the overall advancement of modern medicine and the growing global trend of delaying childbirth until later age, we find ever more younger women diagnosed and treated for BC who have not yet completed their family. Therefore, fertility preservation has emerged as a very important quality of life issue for young BC survivors. This paper reviews currently available options for fertility preservation in young women with early-stage BC and highlights the importance of a multidisciplinary approach to fertility preservation as a very important quality of life issue for young BC survivors. Pregnancy after BC treatment is considered not to be associated with an increased risk of BC recurrence; therefore, it should not be discouraged for those women who want to achieve pregnancy after oncologic treatment. Currently, it is recommended to delay pregnancy for at least 2 years after BC diagnosis, when the risk of recurrence is highest. However, BC patients of reproductive age should be informed about the potential negative effects of oncologic therapy on fertility, as well as on the fertility preservation options available, and if interested in fertility preservation, they should be promptly referred to a reproductive specialist. Early referral to a reproductive specialist is an important factor that increases the likelihood of successful fertility preservation. Embryo and mature oocyte cryopreservation are currently the only established fertility preservation methods but they require ovarian stimulation (OS), which delays initiation of chemotherapy for at least 2 weeks. Controlled OS does not seem to increase the risk of BC recurrence. Other fertility preservation methods (ovarian tissue cryopreservation, cryopreservation of immature oocytes and ovarian suppression with gonadotropin-releasing hormone agonists) do not require OS but are still considered to be experimental techniques for fertility preservation.

Dataset Information

Fertility preservation in women with cancer: a national study about French oncologists awareness, experience, and feelings.

Purpose

Methods

Results

Conclusion

Publications

Fertility preservation in women with cancer: a national study about French oncologists awareness, experience, and feelings.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets